New device could catch colon cancers that stool tests miss

NCT ID NCT07623902

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called Gixam to see if it can find precancerous growths or colon cancer in people aged 45-84 who had a negative stool test (FIT). About 1,436 participants will use the Gixam device, take a home stool test, and then get a standard colonoscopy. The goal is to see if Gixam catches cancers that stool tests miss, improving early detection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MICROBIOME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Blue Ridge Medical Research

    RECRUITING

    Lynchburg, Virginia, 24502, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Comprehensive Gastrointestinal Health, LLC

    RECRUITING

    Northbrook, Illinois, 60062, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Great Lakes Gastroenterology Research, LLC

    RECRUITING

    Mentor, Ohio, 44060, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Orlando Gastroenterology, PA

    RECRUITING

    Orlando, Florida, 32835, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Westchester Putnam Gastro

    RECRUITING

    Carmel, New York, 10549, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••